QVance’s Partnerships Driving Innovation in Advanced Therapies
NextCell Pharma AB*, parent company of QVance, proudly supports QVance’s newly announced partnership with Royale International. This collaboration, which combines…
115,350€
0,65%
Echtzeit-Aktienkurs BioMerieux
Bid:
Ask:
Nachrichten zur BioMerieux Aktie
QVance Announces Partnership
NextCell Pharma AB* comments on its subsidiary QVance’s partnership with bioMérieux Sweden AB, which aims to strengthen quality control analytics…
Clinical Microbiology Market: $5.0B in 2024, Projected 6.5% CAGR to 2029 | MarketsandMarkets™
Chicago, June 17, 2024 (GLOBE NEWSWIRE) -- The clinical microbiology market, valued at $5.0 billion in 2024 and…
Global Companion Diagnostics Market Size To Exceed USD 23.12 Billion By 2033 | CAGR Of 12.50%
The Global Companion Diagnostics Market Size was Valued at USD 7.12 Billion in 2023 and the Worldwide Companion Diagnostics Market…
Enzyme-Linked Immunosorbent Assay Market revenue to hit USD 27 Billion by 2036, says Research Nester
Key enzyme-linked immunosorbent assay market players include Thermo Fisher Scientific Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, F. Hoffmann-La…